Femasys (FEMY) Payables (2020 - 2026)
Femasys' (FEMY) quarterly Payables came in at $2.3 million in Q2 2026, down 74.99% on a YoY basis from $9.3 million in Q2 2025, and up 46.3% quarter-over-quarter from $1.6 million in Q1 2026.
Analysis
Femasys (FEMY) Payables (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Payables for 7 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Payables fell 74.99% year-over-year to $2.3 million; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (down 74.99% YoY), and the FY2025 full-year result was $1.8 million, down 73.19% from the prior year.
- Payables rose to $2.3 million in Q2 2026 per FEMY's latest filing, from $1.6 million in the prior quarter.
- Across five years, Payables topped out at $9.3 million in Q2 2025 and bottomed at $526764.0 in Q1 2023.
- Historically, Payables has averaged $2.3 million across 5 years, with a median of $1.1 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Payables soared 882.06% in 2025, then tumbled 80.26% in 2026.
- Over 5 years, Payables stood at $652056.0 in 2022, then soared by 74.5% to $1.1 million in 2023, then jumped by 499.85% to $6.8 million in 2024, then tumbled by 73.19% to $1.8 million in 2025, then rose by 27.72% to $2.3 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $2.3 million, $1.6 million, and $1.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 5.89 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 277.20 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 2.70 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 2.00 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.23 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 210.50 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 968.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 587.50 Mn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | 2.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.34 Mn |
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 9.34 Mn |
| Mar 31, 2025 | 8.09 Mn |
| Dec 31, 2024 | 6.83 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 951,510.00 |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 546,877.00 |
| Mar 31, 2023 | 526,764.00 |
| Dec 31, 2022 | 652,056.00 |
| Sep 30, 2022 | 699,687.00 |
| Jun 30, 2022 | 846,166.00 |
| Mar 31, 2022 | 594,043.00 |
| Dec 31, 2021 | 626,645.00 |
| Sep 30, 2021 | 757,756.00 |